Monday, 16 December 2024

U.S. Single-use Bioprocessing Market Size To Reach $21.41 Billion By 2030

 The U.S. Single-Use Bioprocessing Market size was estimated at USD 9.34 billion in 2024 and is projected to grow at a CAGR of 15.04% from 2025 to 2030. Due to the high demand for biopharmaceuticals, suppliers have made their disposable product offerings more robust and inclusive. Single-use equipment suppliers are trying to fulfill end users' growing and ever-changing expectations.

The U.S. single-use bioprocessing industry experienced a positive impact from the COVID-19 pandemic, particularly due to the increased demand for single-use products driven by the heightened need for vaccines, treatments, and assays. These products played an important role in facilitating the rapid scaling up of production by biopharmaceutical companies to meet the unprecedented global demand for vaccines. The pandemic underscored the importance of maintaining sterility and minimizing contamination risks in pharmaceutical and biologics production, highlighting the significance of single-use products in such scenarios.

Key U.S. Single-use Bioprocessing Companies:

  • Sartorius AG
  • Danaher
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Avantor, Inc.
  • Eppendorf SE
  • Corning Incorporated
  • Meissner Filtration Products, Inc.
  • Lonza
  • PBS Biotech, Inc.

Request a free sample copy or view report summary: U.S. Single-use Bioprocessing Market

U.S. Single-use Bioprocessing Market Report Highlights

  • The simple & peripheral elements segment held the largest market share of 48.54% in 2024 due to continuous innovations in these products and the increasing prominence of bioprocessing operations in manufacturing.
  • The upstream segment dominated the U.S. market with a share of 57.80% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period.
  • In 2023, biopharmaceutical manufacturers held the largest market share in the end use segment and are anticipated to grow at the fastest CAGR over the forecast period.

Recent Development

  • In August 2024, Freudenberg Medical expanded its biopharma portfolio with custom single-use assemblies, including Y-connector manifolds, tubing, and bottle cap assemblies, for critical fluid transfer in labs and CGMP bioprocesses.
  • In July 2024, Qosina partnered with Polestar Technologies, experts in monitoring O2, CO2, and pH, and added Polestar's iDOT Single-Use Sensor Bag Ports to its product portfolio.
  • In June 2023, Sartorius AG partnered with Waters Corporation to create integrated analytical solutions for downstream biomanufacturing, expanding their existing agreement.
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

No comments:

Post a Comment

Digital Health Market Size To Reach $946.0 Billion By 2030

  The global  Digital Health Market  size is anticipated to reach USD 946.0 billion by 2030 and it is projected to grow at a CAGR of 21.9% f...